Medical Writing Medical Communication Staying ahead of the game in the changing arena of ethical medical communications - Viewpoint of a freelance medical writer
mew-252-front-coverjpg

Volume 25, Issue 2 - Medical Communication

Staying ahead of the game in the changing arena of ethical medical communications - Viewpoint of a freelance medical writer

Abstract

Laws, regulations, pharmaceutical industry codes of practice, and other guidelines play an important role in ethical medical communications. When working on medical education prog - rammes and materials, a professional medical writer must not only consider audience, timelines, and potential content to fulfil client briefs, but also ensure alignment with the appropriate regulations. For medical writers who are freelance, staying informed of evolving laws/codes of practice is essential but may feel like a challenge. However, in an era where information is accessible 24/7, staying ahead of the game is not an impossible task.

Download the full article

References

  1. International Federation of Pharmaceutical Manufacturers & Associations. IFPMA Code of Practice. 2012 [cited 2016 Feb]. Available from: http://www.ifpma.org/wp-content/ uploads/2016/01/IFPMA_Code_of_ Practice_2012_new_logo.pdf
  2. European Federation of Pharma - ceutical Industries and Associations. EFPIA Code on the Promotion of Prescription-only Medicines to, and Interactions with, Healthcare Professionals. 2014 Jun 06 [cited 2016 Feb]. Available from: http://transparency.efpia.eu/uploads/ Modules/Documents/efpia-hcp-code- 2014.pdf
  3. European Federation of Pharma - ceutical Industries and Associations. EFPIA HCP/HCO Disclosure Code. Consolidated Version 2014. 2014 Jun 6 [cited 2016 Feb]. Available from: http:// transparency.efpia.eu/uploads/ Modules/Documents/efpiadisclosure- code-2014.pdf.
  4. Pharmaceutical Research and Manufacturers of America (PhRMA). Code on Interactions with Healthcare Professionals. Updated 2009 Jan [cited 2016 Feb]. Available from: http://www.phrma.org/sites/default/ files/pdf/phrma_marketing_code_ 2008.pdf
  5. Association of the British Pharmaceutical Industry: Code of Practice for the Pharmaceutical Industry 2016 together with the Prescription Medicines Code of Practice Authority. 2016 Jan 01 [cited 2016 Feb]. Available from: http://transparency.efpia.eu/countries /download/27/document/code-ofpractice- 2016.pdf
  6. UK Bribery Act 2010. 2010 Apr 08 [cited 2016 Feb]. Available from: http://www.legislation.gov.uk/ukpga/ 2010/23/contents
  7. Foreign Corrupt Practices Act. Updated November 2012 [cited 2016 Feb]. Available from: http://www. justice.gov/sites/default/files/criminal -fraud/legacy/2015/01/16/guide.pdf
  8. Francer J, Izquierdo JZ, Music T, Narsai K, Nikidis C, Simmonds H, et al. Ethical pharmaceutical promotion and communications worldwide: codes and regulations. Philos Ethics Humanit Med. 2014;9:7.
  9. International Committee of Medical Journal Editors (ICMJE). Recommend ations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. Updated 2015 Dec [cited 2016 Feb]. Available from: http://www.icmje.org/ icmje-recommendations.pdf
  10. Battisti WP, Wager E, Baltzer L, Bridges D, Cairns A, Carswell CI, et al. Good publication practice for commun cating company-sponsored medical research: GPP3. Ann Intern Med. 2015;163(6):461–4.
  11. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Ann Intern Med. 2010;152(11):726–32.
  12. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8): 573–7.
  13. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  14. Hamilton CW, Gertel A, Jacobs A, Marchington J, Weaver S, Woolley K. Mythbusting medical writing: goodbye, ghosts! hello, help! Account Res. 2016;23(3):178–94.
  15. Gattrell WT, Hopewell S, Young K, Farrow P, White R, Wager E, et al. Professional medical writing support and the quality of randomised controlled trial reporting: a crosssectional study. BMJ Open. 2016;6(2):e010329.

Search

Articles

Medical communication writers: Who are they and what do they do?
EMWA News
President's Message
Suggested reading in recent issues of European Science Editing
Medical affairs writing: A key role to relay medical information to everyone
Top ten questions about careers in MedComms
Staying ahead of the game in the changing arena of ethical medical communications - Viewpoint of a freelance medical writer
A PhD and medical writing: A good match
Writing for pharmaceutical or medical device companies: A survey of entry requirements, career paths, quality of life, and personal observations
Medical Gems
The request for proposal process: A brief overview for trainee medical writers
Winners of the Geoff Hall Scholarship Essay Competition
Abstracts from the EMWA Spring Conference Poster Session
News from the EMA
Journal Watch
In the Bookstores
The Webscout
Regulatory Matters
Lingua Franca and Beyond
Gained in Translation
Medical Writing Teaching
Profile - An Interview with Juliane Chaccour - Writing in Mozambique
Letter to the Editor
Out On Our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: